15 employees
Biosynthetic Technologies manufactures biobased synthetic molecules that are made from organic fatty acids found in plant oils.
2006
$9.5M
from 2 investors over 2 rounds
Biosynthetic Technologies raised $7.5M on February 2, 2022
Investors: HG Ventures
Biosynthetic Technologies raised $9.5M on May 7, 2019